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Abstract
AIM: To evaluate the relationship between symptoms
and microscopic colitis (MC) subtypes: to test whether
collagenous colitis (CC) and/or lymphocytic colitis (LC)
might be related to both constipation and diarrhea.
METHODS: A cohort of patients with independently
confirmed typical histopathological changes was
investigated. Fifty-three patients with histologically proved
MC (46 with CC, 7 with LC) were included. The existence
of diarrhea or constipation and the co-existence of
autoimmune diseases were also investigated and all data
were retrospectively analyzed.
RESULTS: Twenty-three (43.39%) of MC patients had
chronic constipation (20 in CC, 3 in LC patients). Twenty-
four (45.28%) of MC patients had autoimmune disease
and the diagnosis of autoimmune disease was always
prior to MC. Sjögren’s syndrome was associated only with
the constipation subgroup.
CONCLUSION: The Janus face of MC resembles the
subgroups of irritable bowel syndrome. The co-existence
of autoimmune diseases and MC is confirmed in both the
constipation and diarrhea subgroups.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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INTRODUCTION
The term “microscopic colitis” was first used in 1980[1].
Notoriously, microscopic colitis (MC) is characterized by
chronic watery diarrhea, a normal or near-normal gross
appearance of the colonic mucosa, and a specific histological
picture. Collagenous colitis (CC) has similar clinical and
histological features. Lindstrom first described it in 1976 as
an unusual cause of persistent watery diarrhea and he noted
a large sub-epithelial band of collagen deposited in the
rectum and colon[2]. Current nomenclature uses MC as an
umbrella term with two major subsets: CC (with chronic
mucosal inflammation and a thickened sub-epithelial collagen
band) and lymphocytic colitis (LC) (with inflammation but
no collagen thickening). Thus, LC and CC are relatively
“new” diseases with a normal colonoscopic appearance but
with characteristic histopathological features. They are well-
distinguished by the presence of the thickened sub-epithelial
collagen table and can cause watery diarrhea. It is likely that
they are a spectrum of one disease, but this is yet to be
proven. Some authors have suggested that LC is an early
stage of CC[3-5]. By colonoscopy and barium enema the
colon appears almost normal. Diagnosis is established by
colonic biopsies. CC can be diagnosed from rectal or
sigmoid colon biopsy specimens in more than 90% of cases.
Arthralgias and various autoimmune conditions occur
commonly in patients with MC and an association has been
suggested[6-8]. Whether CC is a distinct and separate autoimmune
disease or a simple co-existence has not been clearly established.
Data on the pathophysiology of  MC typically come from
small studies that often give conflicting results. Several
hypotheses have been raised, ranging from immune
dysregulation and/or autoimmunity to drug effect and
infection. It may be that the clinicopathological term of
MC encompasses several different diseases with similar
histological endpoints. MC (both CC and LC) can cause
not only diarrhea but also constipation. Most often,
constipation is short-lived and of little consequence in the
ordinary population. However, chronic constipation does
occur[9]. It is not obvious whether the patients suffering
from MC have diarrhea or constipation, all authors premise
the axiom of diarrhea[10]. On the other hand, diseases or
symptoms (i.e., food protein-induced enterocolitis, diarrhea
or constipation) involving the gastrointestinal system have
been attributed to hypersensitive reactions to food. Many
of these symptoms reflect the concept of “delayed” reactions.
This notion presumes that certain clinical symptoms reflect
allergies to food which develop over a period of hours or
days (or longer) and are caused by immunologic mechanisms
ő
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other than immediate-type hypersensitivity[11]. For example,
cow-milk protein allergy should be considered as a cause
of chronic refractory constipation in children, although the
underlying mechanisms still require further investigation.
Dogs and cats have a similar disorder as MC that resolves
with a hypoallergenic diet[12].
Our aim was to determine the natural clinical history of
MC and to obtain more information on this disease on a
cohort of patients from a register set-up at our clinic with
independently confirmed typical histopathological changes.
This study was designed to evaluate the relationship between
symptoms and MC subtypes, to test whether CC and/or
LC might be related to both constipation and diarrhea. We
also investigated the co-existence of autoimmune diseases.
All data were retrospectively analyzed.
MATERIALS AND METHODS
The diagnostic criteria were made on the histopathological
features[13]. The histological features recorded were crypt
architecture distortion, the severity and distribution of
inflammation, surface degeneration, the presence and thickness
of a sub-epithelial collagen band (immunohistochemical
demonstration of tenascin expression), intraepithelial
lymphocytes, any excess of eosinophils or neutrophils and
the presence of apoptosis. (Figure 1).
Figure 1  Colonic mucosa in CC (tenascin immunostaining, ×400).
CC required a subepithelial collagen band of at least
10 µm and an increase in inflammatory infiltrate in the
lamina propria (with a preponderance of plasma cells and
lymphocytes). Patients showing a collagen band without any
inflammatory infiltrate in the lamina propria were excluded.
LC required an increase in the number of intraepithelial
lymphocytes and also chronic inflammation in the lamina
propria. This was assessed in a well-orientated part of the
section. The lamina propria was considered to have an
increase of  chronic inflammatory cells if  the normal gradient
of decrease in inflammatory cells down the lamina propria
was lost and if basal plasma cells were seen at the level of
the upper border of the muscularis mucosae at more than
one site[14].
The Department of  Pathology of  the University of
Debrecen certified the diagnosis of MC (46 with CC, 7
with LC) in the analyzed colonic biopsy specimens between
1994 and 2004. All these paraffin blocks were collected at
the Department of  Pathology. Two independent pathologists
verified the subsequent sections and completed the check
with additional investigations (intraepithelial lymphocytes,
tenascin labeling of the collagen layer, mast cells and
other lamina propria cell components). To avoid bias, all
microscopic slides were coded prior to  analysis by one
observer and read blindly. With this, the histologically verified
patients were re-examined at the Third Department of
Medicine of the University of Debrecen (detailed history
taking and symptoms). Adult patients of both sexes were
included. None of the patients had an infectious disease.
The medical records for these patients were previously
reviewed by investigators and abstracted for patient
characteristics. The diagnoses of gluten sensitive enteropathy
(GSE), Crohn’s disease, allergic asthma, rhinitis and urticaria
were made using the formally accepted criteria. The diagnoses
of systemic lupus erythematosus (SLE), rheumatoid arthritis
(RA), Sjögren’s syndrome (SS), undifferentiated connective
tissue disease (UCTD) and Hashimoto thyreoiditis were
based on American Rheumatism Association criteria. Serum
values of total IgE and antibodies to common food antigens
(milk protein, egg protein, soy protein, tomato and hazelnut)
were also determined and food allergens were detected by
‘‘Allergoset-IgE Food’’ kit (INTEX Diagnostika, Basel).
We used the definition of  diarrhea in case of  more
than 3 bowel movements per day (greater than 250 g
of liquid stool daily) for more than 1 mo. Most of the
patients define their constipation by one or more
symptoms: hard stools, infrequent stools (typically fewer
than three per week), the need for excessive straining, a
sense of incomplete bowel evacuation, and excessive time
spent on the toilet or in unsuccessful defecation. An
epidemiologic study of constipation in USA identified it as
an inability to evacuate stool completely and spontaneously
three or more times per week[15]. A consensus definition of
constipation (the Rome II criteria), used in current work, is
shown in Table 1[16].
Table 1  Rome II criteria for constipation in adults
Two or more of the following for at least 12 wk (not necessarily consecutive) in the
preceding 12 mo:
·  Straining >25% of bowel movements
·  Lumpy or hard stools >25% of bowel movements
·  Sensation of incomplete evacuation >25% of bowel movements
·  Sensation of anorectic blockage >25% of bowel movements
·  Manual maneuvers to facilitate >25% of bowel movements (e.g., digital evacuation
·  or support of the pelvic floor)
·  <3 bowel movements per week
·  No loose stools, and insufficient criteria for irritable bowel syndrome met
Statistical analysis
Statistical analysis was performed using SPSS v11.0 and
Microsoft Excel soft packs. Differences between groups
were tested using the Fisher’s exact test, independent samples
t-test and Mann-Whitney test.
RESULTS
Fifty-three patients had a diagnosis of collagenous or LC
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on the pathology database. All patients’ biopsies were taken
by colonoscopy because of abdominal pain and/or stool
problems (diarrhea or constipation) or weight loss, and
endoscopic evaluation demonstrated normal findings (the
macroscopic picture was normal). Constipation was found
in 23 patients (43.39%, 20 CC and 3 LC patients) and
diarrhea in 30 patients (56.61%, 26 CC and 4 LC patients).
The average age of the CC and LC patients was 51.56 years
(range 26-79) and 43.42 years (range 19-59). The average
age of MC patients with constipation and diarrhea was
54.95 and 47.32 years, respectively. This association was
significant (P = 0.032). The demographic data and symptoms
for each type of  colitis are given in Table 2.
Table 2  Demographic data and symptoms for each type of colitis
    CC (n=46)             LC (n=7)
        Average age: 51.56, n (%)             Average age: 43.42, n (%)
Gender M/F          21/25                   2/5
Diarrhea      26 (56.52)              4 (57.14)
Constipation      20 (43.48)              3 (42.86)
Abdominal pain      18 (39.3)              4 (57.14)
Weight loss      16 (34.78)              2 (28.57)
Cholecystectomy        5 (10.86)   0
Appendectomy        5 (10.86)              2 (28.57)
Allergic disease1      22 (47.82)              2 (28.57)
Autoimmune disease2      22 (47.82)              2 (28.57)
1Allegic disease: asthma, allergic rhinitis, allergic urticaria and/or increased
IgE type antibody titres against food allergens 2Autoimmune disease: SLE,
RA, SS, UCTD, Hashimoto thyreoiditis, Crohn’s disease and celiac disease.
The most common symptoms were abdominal pain and
weight loss, but there was no difference in their incidence.
In CC patients, 5 had a history with appendectomy and 5
with cholecystectomy, and 2 LC patients with appendectomy.
There were 24 patients with clearly defined autoimmune
conditions (GSE and Crohn’s disease also included, as shown
in Figure 2).
Figure 2  Distribution of autoimmune diseases in MC. Crohn’s:
Crohn’s disease GSE: celiac disease H. thyreoiditis: Hashimoto
thyreoiditis UCTD: undifferentiated connective tissue disease SLE:
systemic lupus erythematosus RA: rheumatoid arthritis Sjögren’s:
Sjögren’s syndrome.
Sjögren’s disease was associated only with CC and
constipation. SLE (2 patients with CC and 1 with LC) and
UCTD (2 patients with MC/CC) were associated only with
diarrhea (Figure 3).
Figure 3  Relation between autoimmune diseases and the type of
MC (constipation/diarrhea) Crohn’s: Crohn’s disease GSE: celiac dis-
ease H. thyreoiditis: Hashimoto thyreoiditis UCTD: undifferentiated
connective tissue disease SLE: systemic lupus erythematosus RA:
rheumatoid arthritis Sjögren’s: Sjögren’s syndrome.
The diagnosis of autoimmune disease preceded the
diagnosis of MC in all patients and no significant association
was found between gender and the time of onset of MC.
The average time of onset was 4.12 years in male patients
and 6.56 years in females. Common allergic diseases (asthma,
allergic rhinitis, and allergic urticaria) and/or increased IgE
type antibody titers against food allergens were found in 24
of 53 patients with MC (45.28%), and in 22 (47.82%) CC
patients and in 2 (28.57%) LC patients. IgE type antibodies
against hazelnut, tomato, soy protein, milk protein, egg
protein, and gliadin were found.
Clinical course of the patients was not the same. Most
of the patients with MC had chronic watery diarrhea but
the other group had constipation. Most of them responded
to budesonide (Budenofalk, Dr Falk Pharma, 1×9 mg/d)
and entered a long lasting remission period.
DISCUSSION
Symptoms of MC can cease and patients may have not
any complaints, but intermittent or continuous diarrhea can
remain[17-20]. CC is characterized by diarrhea, lymphocytic
inflammation, and a thickened sub-epithelial collagen layer
in the colorectal mucosa[2]. Frequent watery diarrheas have
the clinical picture of  CC and LC and intermittent or
continuous diarrhea can remain[21]. On the other hand,
numerous cases never suffer from episodes of watery
diarrhea but chronic constipation. We had investigated 53
patients with histologically identified MC. We propose that
MC is a Janus-faced disease as 23 of them had chronic
constipation and 30 had the well-known diarrhea.
There are many reports with several hypotheses on
potential pathophysiological mechanisms in MC. Current
understanding of MC defines it as an inflammatory disorder
of the bowels. Acute inflammation is a beneficial non-specific
response of tissues to injury that generally leads to repair
and restoration of  normal structure and function. MC seems
to be a chronic inflammatory process of the bowels. The
factors that initiate and perpetuate remodeling are incompletely





































understood. It is not clear whether gut remodeling is a normal
response to an injury or whether the remodeling/repair
response is itself  an abnormal response. In addition, while
remodeling is generally believed to be disadvantageous, in
some ways it may serve as a protective function. The balance
between these effects in vivo is speculative. The gut wall of
patients with MC can be characterized by a number of
structural changes and it is not known which one (s) are the
most useful and relevant markers.
Allergy (food allergy) can cause both diarrhea and
constipation. Diseases or symptoms (i.e., food protein-
induced enterocolitis, diarrhea or constipation) involving the
gastrointestinal system have been attributed to hypersensitive
reactions to food[22-25]. Albeit the etiology of  CC is still
unknown but the sub-epithelial band-like collagenous deposit
may be produced by fibroblasts after an immune stimulation.
In case of CC, the mesenchymal cells’ myofibroblastic
transformation occurs within the accumulated sub-epithelial
extra cellular matrix[26,27]. According to the recent data the
bulk of accumulated sub-epithelial extra cellular matrix is
composed of type VI collagen and tenascin[28,29]. The increased
number of mast cells besides the myofibroblasts is
remarkable in the “fibrotic” layer, which is characteristic in
CC. The presence of a different distribution of mast cells
and macrophages in CC and inflammatory bowel disease
suggests that mucosal mast cells play a role in the development
of Th2 response CC rather than Th1[30,31].
Our data support the hypothesis that patients with MC
may have laboratory and/or clinical evidence of allergic
diseases and/or food allergy and these mean a possible
connection between MC and food allergy. Remodeling of
the gut wall is thought to be a result of chronic inflammation.
Since steroids reduce or reverse inflammation, they may
also reduce or reverse remodeling. However, there is also
in vitro evidence for a direct effect of steroids on the cells,
growth factors, and cytokines which are thought to be central
in the remodeling process. Corticosteroids are the most
effective drugs available for the treatment of allergic diseases
because they have potent anti-inflammatory effects. Topical
corticosteroids work by reducing the effects of histamine
and other inflammatory mediators involved in the allergic
response and repeated dosing inhibits both the early and
late phase allergic reactions. All the patients receiving
budesonide had clinical response.
The etiology of  MC is still unknown and more research
is needed. Up to now, it is not clear whether CC is a distinct
entity or only an epiphenomenon of another disease which
leads to thickening of the collagen layer[32, 33]. Whether MC
(both CC and LC) is an autoimmune disease has not been
conclusively established. Autoimmune diseases occur in
patients with MC and an association with various autoimmune
diseases has been suggested, but no serological findings
support such a theory[34-36].
Because of the clinical heterogeneity in our study
population, the descriptive term MC syndrome may be a
more prudent diagnosis than MC. We think that the
frequency of MC will increase with better recognition.
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